Patient-1413
 | |
| ID: | 1413 |
| Name: | Sud |
| Threat level: | Soyclid |
| Filed: | July 28 2023 |
| By: | Dr. Larpson |
Patient File ID: 1413
Threat Level: Soyclid
Containment Level: Soyclid, formerly Safe
Containment Procedure
Patient-1413 is to be kept within a 7x7x7 meter concrete containment chamber, outfitted with basic living amenities and a ventilation system in the floor and ceiling for collection and filtering of soyclohexanol. Patient-1413 is to be fed 1kg of enriched goyslop three times a day, and does NOT require hydration because... it just doesn't, okay?????
In the event of an NT-Ohio incident, MJF QK-Ϫ5 ("Nvkes Of Trvth") is to be deployed to recontain or neutralize Patient-1413, depending on the severity of the incident. So far only one has occurred, which has resulted in the suspension of live or subdued testing of the patient. As of now, Patient-1413 is contained at Site-010's west wing.
Description
Patient-1413 is a 5 foot 8 inch tall humanoid of a pale complexion, possessing a stubble, prominent lips, a long nose and prominent nasolabial folds. In place of regular sweat, the patient exudes a gaseous substance that later becomes a liquid that has been dubbed soyclohexanol. While the effects of soyclohexanol on the body hasn't been fully researched, it is known to cause severe dehydration and inflammation in skin and internal organs if exposed to without sufficient protection. The amount of soyclohexanol exuded by Patient-1413 depends on the levels of stress or anger it is feeling at that point in time. Patient-1413 was created at Site-010 by Researcher Steinbergbaumowitz, under the orders of Site Administration Officer Dr. Larpson, in an attempt to hybridize a Soyjak and Chud. The experiment yielded two offspring, one of which was stillborn and melted into a puddle of semen, the other being Patient-1413. The patient matured to its current state in the following week, to the surprise of Steinbergbaumowitz and his research team.
